BioSpace News Archive

SQZ Biotechnologies, a cell therapy company developing novel treatments for multiple therapeutic areas, announced that Armon Sharei, PhD, chief executive officer of SQZ, and additional management will participate in the following upcoming virtual investor conferences:

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers, announced that Anthony Sun, MD, Chairman and Chief Executive Officer of Zentalis, will participate in two upcoming virtual investor conferences.

The escalating prevalence of diabetes across the world and the existing high price of insulin drugs may prove as significant growth factors for the insulin biosimilars market during the forecast period of 2018-2028.

The demand within the global pulmonary embolism market has been rising on account of advancements in the domain of healthcare, diagnosis, and medical treatment.

From the public safety point of view, it is very important to keep drunk drivers off the roads.

Hypertension is a critical health condition that can lead to cardiovascular diseases, renal failure, stroke, and even death.

Sequana Medical NV, an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, announces that Ian Crosbie, Chief Executive Officer, will present at the Jefferies 2020 Virtual London Healthcare Conference taking place from 17 to 19 November 2020.

On August 13th, we announced a €19.8m acquisition of a majority stake of 62.7% in Genkyotex, a publicly listed life science company in France.

CytoSorbents Corporation announced that the Company will present an overview of the company at the Jefferies Virtual London Healthcare Conference on Tuesday, November 17, 2020 and meet with investors in 1x1 meetings throughout the day.

Ultimovacs ASA, a pharmaceutical company developing novel immunotherapies against cancer, announces its third quarter 2020 results